Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-16 of 16
Keywords: Treatment
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Women's and Children's Health
Antonio Simone Laganà, Andrea Romano, Arne Vanhie, Celine Bafort, Martin Götte, Lauri A. Aaltonen, Aymara Mas, Christine De Bruyn, Thierry Van den Bosch, An Coosemans, Stefano Guerriero, Sergio Haimovich, Vasilios Tanos, Marlies Bongers, Fabio Barra, Ayman Al-Hendy, Vito Chiantera, Umberto Leone Roberti Maggiore
Gynecol Obstet Invest (2024) 89 (2): 73–86.
Published Online: 21 February 2024
... and matched myometrium may enhance our understanding of tumor development compared to histologic analysis and whole tissue transcriptomics, and support the development of minimally invasive treatment strategies; on the other hand, ultrasound imaging allows in most of the cases a proper mapping the fibroids...
Journal Articles
Frédéric Amant, Linda Nooij, Daniela Annibali, Anne-Sophie van Rompuy, Sileny Han, Heidi van den Bulck, Frédéric Goffin
Gynecol Obstet Invest (2018) 83 (6): 620–626.
Published Online: 18 September 2018
... of the size of the tumor and the extension to the anal sphincter, her treatment started with 6 cycles taxol (175 mg/m 2 )-carboplatin (5 × AUC) from April 2015 until August 2015. MRI as well as macroscopic inspection showed partial remission making less extensive surgery possible (Fig. 2 ). In November 2015...
Journal Articles
Joanna Jonska-Gmyrek, Agnieszka Zolciak-Siwinska, Leszek Gmyrek, Wojciech Michalski, Grazyna Poniatowska, Malgorzata Fuksiewicz, Pawel Wiechno, Jakub Kucharz, Maria Kowalska, Beata Kotowicz
Gynecol Obstet Invest (2018) 83 (3): 220–226.
Published Online: 23 January 2018
... the treatment strategy in patients with USCC is an important issue. Methods: MEDLINE (PubMed) was searched for all articles published after the first publication by Lurie et al. [Eur J Obstet Gynecol Reprod Biol 1991; 40: 79–81], reporting woman diagnosed with USCC. Because of limited numbers of studies...
Journal Articles
Gulsum Uysal, Gokhan Acmaz, Yusuf Madendag, Fulya Cagli, Hatice Akkaya, Ilknur Madendag, Eda Ulku Karakilic
Gynecol Obstet Invest (2018) 83 (2): 151–155.
Published Online: 15 July 2017
...Gulsum Uysal; Gokhan Acmaz; Yusuf Madendag; Fulya Cagli; Hatice Akkaya; Ilknur Madendag; Eda Ulku Karakilic Aim: The aim of the study was to compare the effectiveness of dienogest (DIE), depo medroxyprogesterone 17-acetate (MPA), and micronized progesteron (MP) regimens for treatment of simple...
Journal Articles
Gynecol Obstet Invest (2016) 81 (5): 472–476.
Published Online: 15 June 2016
... pregnancy. Myotonia congenita Periodic paralysis CLCN1 gene SCN4A gene Pregnancy Treatment Personal attitude Myotonia congenita is characterized by delayed relaxation of voluntary muscles after contraction and transient muscle weakness. It is mostly caused by muscle...
Journal Articles
Lucas Minig, Maria Guadalupe Patrono, Jose Miguel Cárdenas-Rebollo, Pedro Martin Marfil, Virginia Rodriguez-Tabares, Linus Chuang
Gynecol Obstet Invest (2016) 81 (6): 497–503.
Published Online: 06 April 2016
... Treatment The recommended treatment for women affected by an advanced stage ovarian cancer is based on an aggressive tumor debulking aimed at achieving a complete cytoreduction [ 1 ]. In these cases, para-aortic and pelvic lymphadenectomy seem to have benefits on progression-free survival (PFS...
Journal Articles
Gynecol Obstet Invest (2014) 77 (2): 141–144.
Published Online: 23 January 2014
...Yueling Wang; Qiling Li; Huiping Du; Shulan Lv; Huiting Liu Primary vaginal cancer is not common, representing 1-2% of all female genital malignancies. We present a case of a third-degree uterine prolapse complicated by an isolated primary vaginal cancer and its surgical treatment. The cervix...
Journal Articles
Beatriz de Melo Maia, Flávia Munhoz Cestari, André Mourão Lavorato-Rocha, Iara Sant’Ana Rodrigues, Glauco Baiocchi, Gustavo Cardoso Guimarães, José Vassallo, Mônica Stiepcich, Fernando Augusto Soares, Rafael Malagoli Rocha
Gynecol Obstet Invest (2013) 75 (1): 53–60.
Published Online: 07 December 2012
..., instructions or products referred to in the content or advertisements. Vulvar cancer Treatment Surgery Demographics Clinical pathology Vulvar carcinoma is a disease that accounts for approximately 3–5% of all malignant tumors in the female genital tract [ 1,2,3 ] and has traditionally been...
Journal Articles
Pierluigi Benedetti Panici, Pier Franco Di Roberto, Pasquale Alessandro Margariti, Giovanni Scambia, Adriano Bompiani, Salvatore Mancuso
Gynecol Obstet Invest (1987) 24 (2): 138–144.
Published Online: 15 March 2010
... of 9.8% and 14.2% in stages I and II, respectively, was found. Also evaluated was the influence of some risk factors (histologic grade, myometrial infiltration) on survival rates which was highly significant for both stages I and II. Surgery was the main form of treatment with an operability rate higher...
Journal Articles
Gynecol Obstet Invest (1994) 37 (1): 56–58.
Published Online: 01 March 2010
... to in the content or advertisements. Cervical polyp Treatment Original Paper Gynecol Obstet Invest 1994;37:56-58 A. Golem3 A. Berb I. Wohnanb M.P. Davidb Cervical Polyp: Evaluation of Current Treatment Department of Obstetrics and Gynecology, Assaf Harofeh Medical Center, Affiliated to Sackler Faculty...
Journal Articles
Gynecol Obstet Invest (2010) 69 (3): 203–211.
Published Online: 24 December 2009
..., and recurrences. Results: Results were moderate or good in only 16% of subjects at 3 months and in 33% of subjects at 6 months after treatment in group I; these numbers were 66 and 33%, respectively, in group II. Differences were not statistically significant. However, the evolution of symptoms, endometriomas...
Journal Articles
Gynecol Obstet Invest (2008) 66 (Suppl. 1): 19–27.
Published Online: 21 October 2008
...Marc R. Laufer Endometriosis can occur in adolescents and this patient group presents particular challenges in terms of differential diagnosis, variable presentation and symptoms, and choice of treatment. Early diagnosis is essential in order to decrease pain and hopefully prevent disease...
Journal Articles
Pedro Acién, Gloria Pérez-Albert, Francisco J. Quereda, Marisa Sánchez-Ferrer, Ana García-Almela, Irene Velasco
Gynecol Obstet Invest (2005) 60 (4): 224–231.
Published Online: 09 November 2005
... and conservative surgery for endometriosis were included. Interventions: Treatment with GnRH analogues every 28 days, 3 doses. Under their effect, one or two transvaginal US-guided punctures were performed in order to aspirate the endometriomas, and 3 million IU of rIL-2 were left in the aspirated cysts each time...
Journal Articles
Gynecol Obstet Invest (2001) 52 (2): 119–123.
Published Online: 28 September 2001
...Isolina Bonacho; Salvador Pita; M. Inmaculada Gómez-Besteiro Objective: To determine whether, in addition to treatment with antibiotics, it is necessary to remove the intrauterine device (IUD) to eliminate genital colonization by Actinomyces . Methods: A randomized clinical trial was carried out...
Journal Articles
Gynecol Obstet Invest (2000) 49 (1): 6–11.
Published Online: 06 January 2000
...E. Kucera; M. Schindl; I. Klem; C. Sam; E. Hanzal; H. Kölbl; S. Leodolter; G. Sliutz The main reason for the restricted use of methotrexate in the treatment of ectopic pregnancy (EP) obviously is the fear of tubal rupture in patients with lower abdominal pain after the administration...
Journal Articles
Spyros A. Mesogitis, George J. Daskalakis, Aristides J. Antsaklis, Nick E. Papantoniou, John S. Papageorgiou, Stylianos K. Michalas
Gynecol Obstet Invest (1998) 45 (3): 154–158.
Published Online: 03 April 1998
... chorionic gonadotropin (β-hCG) assays, allows a more conservative treatment. Twenty-six tubal pregnancies, which were managed with local methotrexate (MTX) injection, are presented. A single dose of 10–12.5 mg of MTX was percutaneously injected into the gestational sac under abdominal sonographic control...